Cellect Biotechnology (APOP) Stock Is Flying On Data

Cellect Biotechnology APOP Stock News

Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) is flying in the market this morning, trading on gains of nearly 100%. The gains come after the company issued positive clinical data, exciting investors. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

APOP Stock Flies On Positive Clinical Data

In the press release, Cellect Biotechnology announced the publication of an article in a peer reviewed journal known as Bone Marrow Transplantation. The article covered the transplantation of bone marrow in humans and was titled ‘Ex-vivo FAS-ligand to Improve Allograft Safety’.

In the release, APOP said that it and its academic partners authored the article.

In the paper, the authors outlined the pre-clinical research and demonstrates that engraftment is robust following tranplantation of treated graft, and the graft retains its immune reconstitution and anti-leukemic effects.

In the release, the company reminded investors that it has initiated a Phase 1/2 study in adults undergoing stem cell transplant for the treatmnet of hematological malignancies. The primary endpoint of the study is to evaluate the overall incidence, frequency, and severity of adverse events potentially related to ApoGraft at 180-days following transplantation.

In the release, APOP said that to date, there has not been any safety or tolerability concerns. Moreover, the principal investigator and independent data safety monitoring board agree that no serious adverse events reported during the course of the study were related to the ApoGraft process.

Why The Stock Is Rocketing

While it is great that Cellect Biotechnology did get this article published, it’s not uncommon for companies in early stages of clinical development to announce a publication in a peer-reviewed journal. So, what’s the big deal here?

Well, it seems as though the news may have triggered a short squeeze. Essentially, those that sell stocks short lose money when the values of these stocks head up. With the positive news, APOP stock started to tick up.

As this happened, short sellers have been racing all morning to purchase shares and cover their positions. As such, APOP stock is flying on high volume and could continue higher.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.